N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes-Reference-Cited by-同舟云学术

N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes

Published:2022-01 Issue: Volume:95 Page:153871
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Lin Xian,Tao Cheng,Zhang Ren,Zhang Miaomiao,Wang Qingwen,Chen Jian

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference30 articles.

1. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis;Bartok;Immunol. Rev.,2010

2. P2X7 receptor: a potential therapeutic target for autoimmune diseases;Cao;Autoimmun. Rev.,2019

3. Distinct fibroblast subsets drive inflammation and damage in arthritis;Croft;Nature,2019

4. Potential therapeutic compounds from traditional Chinese medicine targeting endoplasmic reticulum stress to alleviate rheumatoid arthritis;de Seabra Rodrigues Dias;Pharmacol. Res.,2021

5. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases;Efferth;Med. Res. Rev.,2021

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA N6-methyladenosine modification in arthritis: New insights into pathogenesis;Modern Rheumatology;2024-08-23

2. The Role of m6A Methylation in Tumor Immunity and Immune-Associated Disorder;Biomolecules;2024-08-22

3. Liensinine diperchlorate and artemisitene synergistically attenuate breast cancer progression through suppressing PI3K-AKT signaling and their efficiency in breast cancer patient-derived organoids;Biomedicine & Pharmacotherapy;2024-07

4. Novel artesunate and isatin hybrid CT3-1 suppresses collagen-induced arthritis through abrogating dendritic cell chemotaxis-induced by CCR5;International Immunopharmacology;2024-07

5. PTEN: an emerging target in rheumatoid arthritis?;Cell Communication and Signaling;2024-04-26